Dipartimento di Bioscienze, Biotecnologie e Scienze Farmacologiche, Universita degli Studi di Bari, and Istituto di Biomembrane e Bioenergetica, CNR, via Orabona, 4, I-70126 Bari, Italia.
Curr Pharm Des. 2013;19(14):2649-75. doi: 10.2174/1381612811319140014.
The primary role of the water-soluble vitamin B2, i.e. riboflavin, in cell biology is connected with its conversion into FMN and FAD, the cofactors of a large number of dehydrogenases, reductases and oxidases involved in energetic metabolism, redox homeostasis and protein folding as well as in diverse regulatory events. Deficiency of riboflavin in men and experimental animal models has been linked to several diseases, including neuromuscular and neurological disorders and cancer. Riboflavin at pharmacological doses has been shown to play unexpected and incompletely understood regulatory roles. Besides a summary on riboflavin uptake and a survey on riboflavin-related diseases, the main focus of this review is on discovery and characterization of FAD synthase (EC 2.7.7.2) and other components of the cellular networks that ensure flavin cofactor homeostasis.Special attention is devoted to the problem of sub-cellular compartmentalization of cofactor synthesis in eukaryotes, made possible by the existence of different FAD synthase isoforms and specific molecular components involved in flavin trafficking across sub-cellular membranes.Another point addressed in this review is the mechanism of cofactor delivery to nascent apo-proteins, especially those localized into mitochondria, where they integrate FAD in a process that involves additional mitochondrial protein(s) still to be identified. Further efforts are necessary to elucidate the role of riboflavin/FAD network in human pathologies and to exploit the structural differences between human and microbial/fungal FAD synthase as the rational basis for developing novel antibiotic/antimycotic drugs.
水溶性维生素 B2(核黄素)在细胞生物学中的主要作用与其转化为 FMN 和 FAD 有关,FMN 和 FAD 是许多参与能量代谢、氧化还原平衡和蛋白质折叠以及各种调节事件的脱氢酶、还原酶和氧化酶的辅因子。男性和实验动物模型中核黄素的缺乏与多种疾病有关,包括神经肌肉和神经紊乱以及癌症。药理剂量的核黄素已被证明具有意想不到的和不完全理解的调节作用。除了对核黄素摄取的总结和对与核黄素相关疾病的调查外,本综述的主要重点是发现和表征黄素腺嘌呤二核苷酸合酶(EC 2.7.7.2)和其他确保黄素辅因子体内平衡的细胞网络的组成部分。特别关注真核生物中辅因子合成的亚细胞区室化问题,这是通过存在不同的黄素腺嘌呤二核苷酸合酶同工型和参与黄素跨亚细胞膜运输的特定分子成分来实现的。本综述还讨论了将辅因子递送到新生脱辅基蛋白的机制,特别是那些定位于线粒体中的蛋白,在这个过程中,需要额外的线粒体蛋白(尚未确定)将 FAD 整合进去。还需要进一步努力阐明核糖醇/FAD 网络在人类病理学中的作用,并利用人类和微生物/真菌黄素腺嘌呤二核苷酸合酶之间的结构差异,作为开发新型抗生素/抗真菌药物的合理基础。